£795.00

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

The 2023-2028 World Outlook for Drugs for Rheumatoid Arthritis

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days · 24 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 05 September 2026 10 September 2026 16 September 2026 22 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £795 Days at Price

Price Analysis

Most common price: £795 (24 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 24 days

Description

This study covers the world outlook for drugs for rheumatoid arthritis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of drugs for rheumatoid arthritis as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Amgen, Biogen, Bristol-Myers Squibb, F. Hoffman-La Roche, Johnson & Johnson, Merck, Mitsubishi Tanabe Pharma, Pfizer, and UCB Biosciences. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
10 May 2022
Listed Since
04 May 2022

Similar Products You Might Like

The 2027-2032 World Outlook for Drugs for Rheumatoid Arthritis
96% match

The 2027-2032 World Outlook for Drugs for Rheumatoid Arthritis

£890.00 30 Oct 2026
The 2026-2031 World Outlook for Rheumatoid Arthritis Drugs
96% match

The 2026-2031 World Outlook for Rheumatoid Arthritis Drugs

£885.00 23 Oct 2026
The 2023-2028 World Outlook for Companion Animal Drugs
94% match

The 2023-2028 World Outlook for Companion Animal Drugs

£795.00 06 Sep 2026
The 2023-2028 World Outlook for Oral Anti Diabetes Drugs
94% match

The 2023-2028 World Outlook for Oral Anti Diabetes Drugs

£795.00 27 Oct 2026
The 2023-2028 World Outlook for Pharmaceutical Cartridges
94% match

The 2023-2028 World Outlook for Pharmaceutical Cartridges

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Sterile Injectable Drugs
94% match

The 2023-2028 World Outlook for Sterile Injectable Drugs

£795.00 20 Nov 2026
The 2023-2028 World Outlook for Synthetic Statins
94% match

The 2023-2028 World Outlook for Synthetic Statins

£795.00 13 Sep 2026
The 2023-2028 Outlook for Osteoarthritis Treatments in the United States
94% match

The 2023-2028 Outlook for Osteoarthritis Treatments in the United States

£520.00 06 Sep 2026
The 2023-2028 World Outlook for Children's Digestion Medicines
94% match

The 2023-2028 World Outlook for Children's Digestion Medicines

£795.00 13 Sep 2026
The 2023-2028 World Outlook for Cardiac Rhythm Management
94% match

The 2023-2028 World Outlook for Cardiac Rhythm Management

£795.00 27 Oct 2026
The 2023-2028 World Outlook for Medical Morphine
94% match

The 2023-2028 World Outlook for Medical Morphine

£795.00 24 Oct 2026
The 2023-2028 World Outlook for Pet Veterinary Drugs
94% match

The 2023-2028 World Outlook for Pet Veterinary Drugs

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Respiratory Diagnostics for Tuberculosis
94% match

The 2023-2028 World Outlook for Respiratory Diagnostics for Tuberculosis

£795.00 13 Sep 2026
The 2023-2028 World Outlook for Life Science Products
93% match

The 2023-2028 World Outlook for Life Science Products

£795.00 15 Sep 2026
The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in the United States
93% match

The 2023-2028 Outlook for Analgesic Osteoarthritis Treatments in the United States

£520.00 06 Sep 2026
The 2023-2028 World Outlook for Digital Therapeutics Sales
93% match

The 2023-2028 World Outlook for Digital Therapeutics Sales

£795.00 13 Sep 2026
The 2023-2028 World Outlook for Connected Drug Delivery Devices
93% match

The 2023-2028 World Outlook for Connected Drug Delivery Devices

£795.00 20 Nov 2026
The 2023-2028 World Outlook for Medical Imaging Reagents
93% match

The 2023-2028 World Outlook for Medical Imaging Reagents

£795.00 15 Sep 2026
The 2023-2028 World Outlook for Chimeric Antigen Receptor T (CAR-T) Cells
93% match

The 2023-2028 World Outlook for Chimeric Antigen Receptor T (CAR-T) Cells

£795.00 20 Nov 2026
The 2023-2028 World Outlook for Orthopaedic Imaging
93% match

The 2023-2028 World Outlook for Orthopaedic Imaging

£795.00 08 Sep 2026
The 2023-2028 World Outlook for Dental X-Rays
93% match

The 2023-2028 World Outlook for Dental X-Rays

£795.00 27 Oct 2026
The 2023-2028 World Outlook for Thrombin
93% match

The 2023-2028 World Outlook for Thrombin

£795.00 14 Nov 2026
The 2023-2028 World Outlook for Ligament Stabilizers
93% match

The 2023-2028 World Outlook for Ligament Stabilizers

£795.00 27 Oct 2026
The 2023-2028 World Outlook for Dermatophytic Onychomycosis Therapeutics
93% match

The 2023-2028 World Outlook for Dermatophytic Onychomycosis Therapeutics

£795.00 20 Nov 2026